Global RNA Interference Therapy Market Research Report 2025(Status and Outlook)

March 2025 | 168 pages | ID: GEC6794AC31CEN
Bosson Research

Abstracts

Report Overview

RNA Interference Therapy, or RNAi Therapy, is a cutting-edge medical approach that utilizes small RNA molecules to selectively silence or regulate targeted genes. This therapeutic method involves introducing synthetic small interfering RNA (siRNA) or microRNA (miRNA) into cells, triggering a natural biological process that inhibits the expression of disease-related genes. RNA Interference Therapy shows promise in treating various conditions, including genetic disorders, viral infections, and certain cancers. By leveraging the specificity of RNA molecules, this therapy holds the potential to revolutionize precision medicine by addressing the root causes of diseases at the genetic level, promoting targeted and personalized treatment strategies.

This report provides a deep insight into the global RNA Interference Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNA Interference Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNA Interference Therapy market in any manner.

Global RNA Interference Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Silence Therapeutics

Arrowhead Pharmaceuticals

Janssen Research & Development

Sylentis

Sirnaomics

Dicerna Pharmaceuticals

Alnylam Pharmaceuticals

Silenseed

Vir Biotechnology

OliX Pharmaceuticals

Bio-Path Holdings

Suzhou Ribo Life Science

Market Segmentation (by Type)

siRNA

miRNA

shRNA

piRNA

Market Segmentation (by Application)

Cancer Treatment

Hereditary Disease

Infectious Disease

Nervous System Disease

Diseases of Immune System

Cardiovascular Disease

Metabolic Disease

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the RNA Interference Therapy Market
• Overview of the regional outlook of the RNA Interference Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNA Interference Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of RNA Interference Therapy
1.2 Key Market Segments
  1.2.1 RNA Interference Therapy Segment by Type
  1.2.2 RNA Interference Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 RNA INTERFERENCE THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global RNA Interference Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global RNA Interference Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 RNA INTERFERENCE THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global RNA Interference Therapy Product Life Cycle
3.3 Global RNA Interference Therapy Sales by Manufacturers (2020-2025)
3.4 Global RNA Interference Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 RNA Interference Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global RNA Interference Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers RNA Interference Therapy Manufacturing Sites, Area Served, Product Type
3.8 RNA Interference Therapy Market Competitive Situation and Trends
  3.8.1 RNA Interference Therapy Market Concentration Rate
  3.8.2 Global 5 and 10 Largest RNA Interference Therapy Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 RNA INTERFERENCE THERAPY INDUSTRY CHAIN ANALYSIS

4.1 RNA Interference Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF RNA INTERFERENCE THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global RNA Interference Therapy Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to RNA Interference Therapy Market
5.7 ESG Ratings of Leading Companies

6 RNA INTERFERENCE THERAPY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNA Interference Therapy Sales Market Share by Type (2020-2025)
6.3 Global RNA Interference Therapy Market Size Market Share by Type (2020-2025)
6.4 Global RNA Interference Therapy Price by Type (2020-2025)

7 RNA INTERFERENCE THERAPY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNA Interference Therapy Market Sales by Application (2020-2025)
7.3 Global RNA Interference Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global RNA Interference Therapy Sales Growth Rate by Application (2020-2025)

8 RNA INTERFERENCE THERAPY MARKET SALES BY REGION

8.1 Global RNA Interference Therapy Sales by Region
  8.1.1 Global RNA Interference Therapy Sales by Region
  8.1.2 Global RNA Interference Therapy Sales Market Share by Region
8.2 Global RNA Interference Therapy Market Size by Region
  8.2.1 Global RNA Interference Therapy Market Size by Region
  8.2.2 Global RNA Interference Therapy Market Size Market Share by Region
8.3 North America
  8.3.1 North America RNA Interference Therapy Sales by Country
  8.3.2 North America RNA Interference Therapy Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe RNA Interference Therapy Sales by Country
  8.4.2 Europe RNA Interference Therapy Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific RNA Interference Therapy Sales by Region
  8.5.2 Asia Pacific RNA Interference Therapy Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America RNA Interference Therapy Sales by Country
  8.6.2 South America RNA Interference Therapy Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa RNA Interference Therapy Sales by Region
  8.7.2 Middle East and Africa RNA Interference Therapy Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 RNA INTERFERENCE THERAPY MARKET PRODUCTION BY REGION

9.1 Global Production of RNA Interference Therapy by Region(2020-2025)
9.2 Global RNA Interference Therapy Revenue Market Share by Region (2020-2025)
9.3 Global RNA Interference Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America RNA Interference Therapy Production
  9.4.1 North America RNA Interference Therapy Production Growth Rate (2020-2025)
  9.4.2 North America RNA Interference Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe RNA Interference Therapy Production
  9.5.1 Europe RNA Interference Therapy Production Growth Rate (2020-2025)
  9.5.2 Europe RNA Interference Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan RNA Interference Therapy Production (2020-2025)
  9.6.1 Japan RNA Interference Therapy Production Growth Rate (2020-2025)
  9.6.2 Japan RNA Interference Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China RNA Interference Therapy Production (2020-2025)
  9.7.1 China RNA Interference Therapy Production Growth Rate (2020-2025)
  9.7.2 China RNA Interference Therapy Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Silence Therapeutics
  10.1.1 Silence Therapeutics Basic Information
  10.1.2 Silence Therapeutics RNA Interference Therapy Product Overview
  10.1.3 Silence Therapeutics RNA Interference Therapy Product Market Performance
  10.1.4 Silence Therapeutics Business Overview
  10.1.5 Silence Therapeutics SWOT Analysis
  10.1.6 Silence Therapeutics Recent Developments
10.2 Arrowhead Pharmaceuticals
  10.2.1 Arrowhead Pharmaceuticals Basic Information
  10.2.2 Arrowhead Pharmaceuticals RNA Interference Therapy Product Overview
  10.2.3 Arrowhead Pharmaceuticals RNA Interference Therapy Product Market Performance
  10.2.4 Arrowhead Pharmaceuticals Business Overview
  10.2.5 Arrowhead Pharmaceuticals SWOT Analysis
  10.2.6 Arrowhead Pharmaceuticals Recent Developments
10.3 Janssen Research and Development
  10.3.1 Janssen Research and Development Basic Information
  10.3.2 Janssen Research and Development RNA Interference Therapy Product Overview
  10.3.3 Janssen Research and Development RNA Interference Therapy Product Market Performance
  10.3.4 Janssen Research and Development Business Overview
  10.3.5 Janssen Research and Development SWOT Analysis
  10.3.6 Janssen Research and Development Recent Developments
10.4 Sylentis
  10.4.1 Sylentis Basic Information
  10.4.2 Sylentis RNA Interference Therapy Product Overview
  10.4.3 Sylentis RNA Interference Therapy Product Market Performance
  10.4.4 Sylentis Business Overview
  10.4.5 Sylentis Recent Developments
10.5 Sirnaomics
  10.5.1 Sirnaomics Basic Information
  10.5.2 Sirnaomics RNA Interference Therapy Product Overview
  10.5.3 Sirnaomics RNA Interference Therapy Product Market Performance
  10.5.4 Sirnaomics Business Overview
  10.5.5 Sirnaomics Recent Developments
10.6 Dicerna Pharmaceuticals
  10.6.1 Dicerna Pharmaceuticals Basic Information
  10.6.2 Dicerna Pharmaceuticals RNA Interference Therapy Product Overview
  10.6.3 Dicerna Pharmaceuticals RNA Interference Therapy Product Market Performance
  10.6.4 Dicerna Pharmaceuticals Business Overview
  10.6.5 Dicerna Pharmaceuticals Recent Developments
10.7 Alnylam Pharmaceuticals
  10.7.1 Alnylam Pharmaceuticals Basic Information
  10.7.2 Alnylam Pharmaceuticals RNA Interference Therapy Product Overview
  10.7.3 Alnylam Pharmaceuticals RNA Interference Therapy Product Market Performance
  10.7.4 Alnylam Pharmaceuticals Business Overview
  10.7.5 Alnylam Pharmaceuticals Recent Developments
10.8 Silenseed
  10.8.1 Silenseed Basic Information
  10.8.2 Silenseed RNA Interference Therapy Product Overview
  10.8.3 Silenseed RNA Interference Therapy Product Market Performance
  10.8.4 Silenseed Business Overview
  10.8.5 Silenseed Recent Developments
10.9 Vir Biotechnology
  10.9.1 Vir Biotechnology Basic Information
  10.9.2 Vir Biotechnology RNA Interference Therapy Product Overview
  10.9.3 Vir Biotechnology RNA Interference Therapy Product Market Performance
  10.9.4 Vir Biotechnology Business Overview
  10.9.5 Vir Biotechnology Recent Developments
10.10 OliX Pharmaceuticals
  10.10.1 OliX Pharmaceuticals Basic Information
  10.10.2 OliX Pharmaceuticals RNA Interference Therapy Product Overview
  10.10.3 OliX Pharmaceuticals RNA Interference Therapy Product Market Performance
  10.10.4 OliX Pharmaceuticals Business Overview
  10.10.5 OliX Pharmaceuticals Recent Developments
10.11 Bio-Path Holdings
  10.11.1 Bio-Path Holdings Basic Information
  10.11.2 Bio-Path Holdings RNA Interference Therapy Product Overview
  10.11.3 Bio-Path Holdings RNA Interference Therapy Product Market Performance
  10.11.4 Bio-Path Holdings Business Overview
  10.11.5 Bio-Path Holdings Recent Developments
10.12 Suzhou Ribo Life Science
  10.12.1 Suzhou Ribo Life Science Basic Information
  10.12.2 Suzhou Ribo Life Science RNA Interference Therapy Product Overview
  10.12.3 Suzhou Ribo Life Science RNA Interference Therapy Product Market Performance
  10.12.4 Suzhou Ribo Life Science Business Overview
  10.12.5 Suzhou Ribo Life Science Recent Developments

11 RNA INTERFERENCE THERAPY MARKET FORECAST BY REGION

11.1 Global RNA Interference Therapy Market Size Forecast
11.2 Global RNA Interference Therapy Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe RNA Interference Therapy Market Size Forecast by Country
  11.2.3 Asia Pacific RNA Interference Therapy Market Size Forecast by Region
  11.2.4 South America RNA Interference Therapy Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of RNA Interference Therapy by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global RNA Interference Therapy Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of RNA Interference Therapy by Type (2026-2033)
  12.1.2 Global RNA Interference Therapy Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of RNA Interference Therapy by Type (2026-2033)
12.2 Global RNA Interference Therapy Market Forecast by Application (2026-2033)
  12.2.1 Global RNA Interference Therapy Sales (K MT) Forecast by Application
  12.2.2 Global RNA Interference Therapy Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNA Interference Therapy Market Size Comparison by Region (M USD)
Table 5. Global RNA Interference Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global RNA Interference Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global RNA Interference Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global RNA Interference Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Interference Therapy as of 2024)
Table 10. Global Market RNA Interference Therapy Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers RNA Interference Therapy Manufacturing Sites and Area Served
Table 12. Manufacturers RNA Interference Therapy Product Type
Table 13. Global RNA Interference Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. RNA Interference Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global RNA Interference Therapy Sales by Type (K MT)
Table 25. Global RNA Interference Therapy Market Size by Type (M USD)
Table 26. Global RNA Interference Therapy Sales (K MT) by Type (2020-2025)
Table 27. Global RNA Interference Therapy Sales Market Share by Type (2020-2025)
Table 28. Global RNA Interference Therapy Market Size (M USD) by Type (2020-2025)
Table 29. Global RNA Interference Therapy Market Size Share by Type (2020-2025)
Table 30. Global RNA Interference Therapy Price (USD/MT) by Type (2020-2025)
Table 31. Global RNA Interference Therapy Sales (K MT) by Application
Table 32. Global RNA Interference Therapy Market Size by Application
Table 33. Global RNA Interference Therapy Sales by Application (2020-2025) & (K MT)
Table 34. Global RNA Interference Therapy Sales Market Share by Application (2020-2025)
Table 35. Global RNA Interference Therapy Market Size by Application (2020-2025) & (M USD)
Table 36. Global RNA Interference Therapy Market Share by Application (2020-2025)
Table 37. Global RNA Interference Therapy Sales Growth Rate by Application (2020-2025)
Table 38. Global RNA Interference Therapy Sales by Region (2020-2025) & (K MT)
Table 39. Global RNA Interference Therapy Sales Market Share by Region (2020-2025)
Table 40. Global RNA Interference Therapy Market Size by Region (2020-2025) & (M USD)
Table 41. Global RNA Interference Therapy Market Size Market Share by Region (2020-2025)
Table 42. North America RNA Interference Therapy Sales by Country (2020-2025) & (K MT)
Table 43. North America RNA Interference Therapy Market Size by Country (2020-2025) & (M USD)
Table 44. Europe RNA Interference Therapy Sales by Country (2020-2025) & (K MT)
Table 45. Europe RNA Interference Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific RNA Interference Therapy Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific RNA Interference Therapy Market Size by Region (2020-2025) & (M USD)
Table 48. South America RNA Interference Therapy Sales by Country (2020-2025) & (K MT)
Table 49. South America RNA Interference Therapy Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa RNA Interference Therapy Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa RNA Interference Therapy Market Size by Region (2020-2025) & (M USD)
Table 52. Global RNA Interference Therapy Production (K MT) by Region(2020-2025)
Table 53. Global RNA Interference Therapy Revenue (US$ Million) by Region (2020-2025)
Table 54. Global RNA Interference Therapy Revenue Market Share by Region (2020-2025)
Table 55. Global RNA Interference Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America RNA Interference Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe RNA Interference Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan RNA Interference Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China RNA Interference Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Silence Therapeutics Basic Information
Table 61. Silence Therapeutics RNA Interference Therapy Product Overview
Table 62. Silence Therapeutics RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Silence Therapeutics Business Overview
Table 64. Silence Therapeutics SWOT Analysis
Table 65. Silence Therapeutics Recent Developments
Table 66. Arrowhead Pharmaceuticals Basic Information
Table 67. Arrowhead Pharmaceuticals RNA Interference Therapy Product Overview
Table 68. Arrowhead Pharmaceuticals RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Arrowhead Pharmaceuticals Business Overview
Table 70. Arrowhead Pharmaceuticals SWOT Analysis
Table 71. Arrowhead Pharmaceuticals Recent Developments
Table 72. Janssen Research and Development Basic Information
Table 73. Janssen Research and Development RNA Interference Therapy Product Overview
Table 74. Janssen Research and Development RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Janssen Research and Development Business Overview
Table 76. Janssen Research and Development SWOT Analysis
Table 77. Janssen Research and Development Recent Developments
Table 78. Sylentis Basic Information
Table 79. Sylentis RNA Interference Therapy Product Overview
Table 80. Sylentis RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Sylentis Business Overview
Table 82. Sylentis Recent Developments
Table 83. Sirnaomics Basic Information
Table 84. Sirnaomics RNA Interference Therapy Product Overview
Table 85. Sirnaomics RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Sirnaomics Business Overview
Table 87. Sirnaomics Recent Developments
Table 88. Dicerna Pharmaceuticals Basic Information
Table 89. Dicerna Pharmaceuticals RNA Interference Therapy Product Overview
Table 90. Dicerna Pharmaceuticals RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Dicerna Pharmaceuticals Business Overview
Table 92. Dicerna Pharmaceuticals Recent Developments
Table 93. Alnylam Pharmaceuticals Basic Information
Table 94. Alnylam Pharmaceuticals RNA Interference Therapy Product Overview
Table 95. Alnylam Pharmaceuticals RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Alnylam Pharmaceuticals Business Overview
Table 97. Alnylam Pharmaceuticals Recent Developments
Table 98. Silenseed Basic Information
Table 99. Silenseed RNA Interference Therapy Product Overview
Table 100. Silenseed RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Silenseed Business Overview
Table 102. Silenseed Recent Developments
Table 103. Vir Biotechnology Basic Information
Table 104. Vir Biotechnology RNA Interference Therapy Product Overview
Table 105. Vir Biotechnology RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Vir Biotechnology Business Overview
Table 107. Vir Biotechnology Recent Developments
Table 108. OliX Pharmaceuticals Basic Information
Table 109. OliX Pharmaceuticals RNA Interference Therapy Product Overview
Table 110. OliX Pharmaceuticals RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. OliX Pharmaceuticals Business Overview
Table 112. OliX Pharmaceuticals Recent Developments
Table 113. Bio-Path Holdings Basic Information
Table 114. Bio-Path Holdings RNA Interference Therapy Product Overview
Table 115. Bio-Path Holdings RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Bio-Path Holdings Business Overview
Table 117. Bio-Path Holdings Recent Developments
Table 118. Suzhou Ribo Life Science Basic Information
Table 119. Suzhou Ribo Life Science RNA Interference Therapy Product Overview
Table 120. Suzhou Ribo Life Science RNA Interference Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Suzhou Ribo Life Science Business Overview
Table 122. Suzhou Ribo Life Science Recent Developments
Table 123. Global RNA Interference Therapy Sales Forecast by Region (2026-2033) & (K MT)
Table 124. Global RNA Interference Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 125. North America RNA Interference Therapy Sales Forecast by Country (2026-2033) & (K MT)
Table 126. North America RNA Interference Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 127. Europe RNA Interference Therapy Sales Forecast by Country (2026-2033) & (K MT)
Table 128. Europe RNA Interference Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Asia Pacific RNA Interference Therapy Sales Forecast by Region (2026-2033) & (K MT)
Table 130. Asia Pacific RNA Interference Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. South America RNA Interference Therapy Sales Forecast by Country (2026-2033) & (K MT)
Table 132. South America RNA Interference Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Middle East and Africa RNA Interference Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 134. Middle East and Africa RNA Interference Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Global RNA Interference Therapy Sales Forecast by Type (2026-2033) & (K MT)
Table 136. Global RNA Interference Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 137. Global RNA Interference Therapy Price Forecast by Type (2026-2033) & (USD/MT)
Table 138. Global RNA Interference Therapy Sales (K MT) Forecast by Application (2026-2033)
Table 139. Global RNA Interference Therapy Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of RNA Interference Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNA Interference Therapy Market Size (M USD), 2024-2033
Figure 5. Global RNA Interference Therapy Market Size (M USD) (2020-2033)
Figure 6. Global RNA Interference Therapy Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNA Interference Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global RNA Interference Therapy Product Life Cycle
Figure 13. RNA Interference Therapy Sales Share by Manufacturers in 2024
Figure 14. Global RNA Interference Therapy Revenue Share by Manufacturers in 2024
Figure 15. RNA Interference Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market RNA Interference Therapy Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by RNA Interference Therapy Revenue in 2024
Figure 18. Industry Chain Map of RNA Interference Therapy
Figure 19. Global RNA Interference Therapy Market PEST Analysis
Figure 20. Global RNA Interference Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global RNA Interference Therapy Market Share by Type
Figure 27. Sales Market Share of RNA Interference Therapy by Type (2020-2025)
Figure 28. Sales Market Share of RNA Interference Therapy by Type in 2024
Figure 29. Market Size Share of RNA Interference Therapy by Type (2020-2025)
Figure 30. Market Size Share of RNA Interference Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global RNA Interference Therapy Market Share by Application
Figure 33. Global RNA Interference Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global RNA Interference Therapy Sales Market Share by Application in 2024
Figure 35. Global RNA Interference Therapy Market Share by Application (2020-2025)
Figure 36. Global RNA Interference Therapy Market Share by Application in 2024
Figure 37. Global RNA Interference Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global RNA Interference Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global RNA Interference Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America RNA Interference Therapy Sales Market Share by Country in 2024
Figure 43. North America RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America RNA Interference Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada RNA Interference Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada RNA Interference Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico RNA Interference Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico RNA Interference Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe RNA Interference Therapy Sales Market Share by Country in 2024
Figure 53. Europe RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe RNA Interference Therapy Market Size Market Share by Country in 2024
Figure 55. Germany RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific RNA Interference Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific RNA Interference Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific RNA Interference Therapy Market Size Market Share by Region in 2024
Figure 68. China RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America RNA Interference Therapy Sales and Growth Rate (K MT)
Figure 79. South America RNA Interference Therapy Sales Market Share by Country in 2024
Figure 80. South America RNA Interference Therapy Market Size and Growth Rate (M USD)
Figure 81. South America RNA Interference Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa RNA Interference Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa RNA Interference Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa RNA Interference Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa RNA Interference Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa RNA Interference Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa RNA Interference Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global RNA Interference Therapy Production Market Share by Region (2020-2025)
Figure 103. North America RNA Interference Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe RNA Interference Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan RNA Interference Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China RNA Interference Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global RNA Interference Therapy Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global RNA Interference Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global RNA Interference Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global RNA Interference Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global RNA Interference Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global RNA Interference Therapy Market Share Forecast by Application (2026-2033)